Back

Aberrant retinal structure and vasculature in mouse models of dominant retinopathies caused by CRX homeodomain mutations

Sun, C.; Pfeifer, C. W.; Zheng, Y.; Apte, R. S.; Chen, S.

2026-03-23 neuroscience
10.64898/2026.03.19.712925 bioRxiv
Show abstract

CRX is a transcription factor essential for photoreceptor differentiation and functional development. Two missense mutations in CRX homeodomain, CRXE80A and CRXK88N, are linked to early-onset dominant retinopathies. Molecular studies have revealed distinct profiles of perturbed gene expression in differentiating photoreceptors of knock-in mouse models, resulting from altered DNA binding activities of mutant CRX proteins. This study characterizes concurrent retinal and vascular alterations in knock-in mouse models. Fated cones are present in heterozygous and homozygous CrxE80A and CrxK88N mutants at birth, but subsequent cone differentiation is rapidly compromised. Expression of rod marker rhodopsin (RHO) is absent in CrxK88N/Nretinae but present in other mutants through adulthood. Notably, as compared to wildtype controls, RHO expression is prematurely activated in neonatal CrxE80A mutants. Among tested mutants, only CrxE80A/+retinae elaborate rod outer segments but still lose visual function by young adulthood. The presence of irregular retinal rosettes is a striking pathological phenotype in all mutants. Retinal rosettes displace the localization of inner neurons without affecting their cell numbers during retinal development. Retinal vessels develop close contact with rosette structures. In summary, disrupted photoreceptor differentiation leads to the loss of visual function and formation of retinal rosettes. The presence of retinal rosettes secondarily impairs the localization of inner neurons and vasculature. A deeper understanding of these cellular underpinnings will inform pathogenesis of CRX homeodomain mutations.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
PLOS Genetics
756 papers in training set
Top 0.8%
12.6%
2
Nature Communications
4913 papers in training set
Top 22%
8.5%
3
Human Molecular Genetics
130 papers in training set
Top 0.2%
7.2%
4
Scientific Reports
3102 papers in training set
Top 14%
6.9%
5
Investigative Opthalmology & Visual Science
37 papers in training set
Top 0.2%
4.9%
6
eLife
5422 papers in training set
Top 20%
4.3%
7
JCI Insight
241 papers in training set
Top 0.9%
4.3%
8
PLOS ONE
4510 papers in training set
Top 36%
4.0%
50% of probability mass above
9
Disease Models & Mechanisms
119 papers in training set
Top 0.5%
3.1%
10
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 29%
1.9%
11
The FASEB Journal
175 papers in training set
Top 0.8%
1.9%
12
Cell Death & Disease
126 papers in training set
Top 0.9%
1.7%
13
International Journal of Molecular Sciences
453 papers in training set
Top 7%
1.7%
14
Neurobiology of Disease
134 papers in training set
Top 3%
1.7%
15
Journal of Comparative Neurology
66 papers in training set
Top 0.4%
1.5%
16
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 0.4%
1.3%
17
Investigative Ophthalmology & Visual Science
22 papers in training set
Top 0.2%
1.3%
18
BMC Medical Genomics
36 papers in training set
Top 0.6%
1.3%
19
Journal of Clinical Investigation
164 papers in training set
Top 4%
1.2%
20
npj Genomic Medicine
33 papers in training set
Top 0.5%
1.2%
21
The American Journal of Pathology
31 papers in training set
Top 0.3%
1.0%
22
Cell Reports
1338 papers in training set
Top 29%
1.0%
23
Journal of Biological Chemistry
641 papers in training set
Top 3%
0.9%
24
Molecular Therapy
71 papers in training set
Top 2%
0.9%
25
EMBO Molecular Medicine
85 papers in training set
Top 3%
0.9%
26
eneuro
389 papers in training set
Top 8%
0.8%
27
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 8%
0.8%
28
Acta Neuropathologica Communications
81 papers in training set
Top 1%
0.8%
29
The Journal of Neuroscience
928 papers in training set
Top 8%
0.8%
30
Frontiers in Neurology
91 papers in training set
Top 5%
0.8%